BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Neurolief to Showcase Proliv®Rx at APA 2026, Highlighting FDA-Approved, Physician-Directed At-Home Brain Stimulation for Major Depressive Disorder

  May 12, 2026

   · 

  5 min read
• Press Releases

  Cathetrix and TubeX to Showcase Advanced Catheter Securement Solutions at WHX 2026

  May 12, 2026

   · 

  2 min read
• Press Releases

  Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress

  May 12, 2026

   · 

  11 min read
• Press Releases

  IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients

  May 12, 2026

   · 

  9 min read
• Press Releases

  Evergreen Nephrology Appoints Eugenia Timm as Chief Operating Officer

  May 12, 2026

   · 

  2 min read
• Press Releases

  Phio Pharmaceuticals Announces “Innovations in Skin Cancer Treatment and Prevention” in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026

  Live virtual fireside chat — investors, advisors, and life sciences analysts invited to attend Featuring Dermatologist Mary Spellman, M.D., with Phio CEO Robert Bitterman and Force Family Office CEO Steven Saltzstein

  May 12, 2026

   · 

  5 min read
• Press Releases

  EktaH Shows ~50% Reduction in Post-GLP-1 Weight Rebound with Novel Obesity Treatment and Reports Positive Phase I Data

  · First-in-class oral mechanism triggers natural satiety hormones, addressing key limitations of GLP-1 therapies · Phase I data demonstrate fat mass reduction, preservation of lean mass, 80% responder rate, and no serious adverse events

  May 12, 2026

   · 

  1 min read
• Press Releases

  Fusion Biopsy Market Size Worth USD 803.50 Mn by 2035 Amid Rising Adoption of Precision Prostate Cancer Diagnostics

  May 12, 2026

   · 

  1 min read
• Press Releases

  U.S. Biopharmaceutical Third-party Logistics Market to Hit USD 118.06 Bn by 2035

  May 12, 2026

   · 

  1 min read
• Press Releases

  DIMERx Preclinical Data Confirms DMX-101 Non-Addictive Profile: No Reinforcement, No Dependence

  Key Regulatory Benchmark Met, Differentiating DMX-101 from Traditional Opioid Analgesics Late-Breaking Results to be Presented at CPDD 2026 Annual Meeting

  May 12, 2026

   · 

  5 min read